Breast cancer in China (Q38215704)

31 August 2017

Breast cancer in China (English)

1 reference

People's Republic of China

31 August 2017

1 reference

1 reference

Kathrin Strasser-Weippl

2

object named as

Kathrin Strasser-Weippl

1 reference

31 August 2017

Lei Fan

1

1 reference

31 August 2017

Jun-Jie Li

3

1 reference

31 August 2017

Jessica St Louis

4

1 reference

31 August 2017

Dianne M Finkelstein

5

1 reference

31 August 2017

Ke-Da Yu

6

1 reference

31 August 2017

Wan-Qing Chen

7

1 reference

31 August 2017

Zhi-Ming Shao

8

1 reference

31 August 2017

Paul E Goss

9

1 reference

31 August 2017

1 June 2014

1 reference

Lancet Oncology Commission

31 August 2017

1 reference

31 August 2017

15

1 reference

31 August 2017

7

1 reference

31 August 2017

e279-89

1 reference

Breast cancer in a transitional society over 18 years: trends and present status in Shanghai, China

31 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Effects of reproductive and demographic changes on breast cancer incidence in China: a modeling analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Chinese doctors' salaries

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

China tackles illness-led poverty as financing gap grows

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Trends in access to health services and financial protection in China between 2003 and 2011: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Planning cancer control in Latin America and the Caribbean

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Cancer burden in China: a Bayesian approach

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Significant difference in the trends of female breast cancer incidence between Taiwanese and Caucasian Americans: implications from age-period-cohort analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Age-period-cohort projections of breast cancer incidence in a rapidly transitioning Chinese population.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Trends in breast cancer incidence in Hong Kong between 1973 and 1999: an age-period-cohort analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Profound changes in breast cancer incidence may reflect changes into a Westernized lifestyle: a comparative population-based study in Singapore and Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

The increase of female breast cancer incidence in Japan: emergence of birth cohort effect

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Reversed urban-rural differences in breast cancer mortality (China, 2002-2008).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

A case-control study on risk factors of breast cancer in China

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer Study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

The changes in female physical and childbearing characteristics in China and potential association with risk of breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Association of hormone-related characteristics and breast cancer risk by estrogen receptor/progesterone receptor status in the shanghai breast cancer study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Association of body size and fat distribution with risk of breast cancer among Chinese women.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Soy food intake and breast cancer survival

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Adult weight change and risk of postmenopausal breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Risk factors for breast cancer in China: similarities and differences with western populations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Assessing the risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Application of breast cancer risk prediction models in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Combined effects of body size, parity, and menstrual events on breast cancer incidence in seven countries

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Risk factors for breast carcinoma in Singaporean Chinese women: the role of central obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

A nation-wide multicenter 10-year (1999-2008) retrospective clinical epidemiological study of female breast cancer in China

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Cost effectiveness of mammography screening for Chinese women

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Breast cancer management in middle-resource countries (MRCs): consensus statement from the Breast Health Global Initiative.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Socioeconomic differences in attitudes and beliefs about healthy lifestyles

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Cultural barriers to mammography, clinical breast exam, and breast self-exam among Chinese-American women 60 and older

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Current status of diagnosis and treatment of primary breast cancer in beijing, 2008.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

What proportion of breast cancers are detected by mammography in the United States?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Analysis of sonographic features for the differentiation of benign and malignant breast tumors of different sizes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Randomized trial of breast self-examination in Shanghai: final results

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Attitudes of midwifery students towards teaching breast-self examination

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Breast self examination

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Characteristics associated with differences in survival among black and white women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Delay in surgical treatment and survival after breast cancer diagnosis in young women by race/ethnicity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Conservation of breast cancer molecular subtypes and transcriptional patterns of tumor progression across distinct ethnic populations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

The pathologic characteristics of breast cancer in China and its shift during 1999-2008: a national-wide multicenter cross-sectional image over 10 years.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Unfavourable clinicopathologic features and low response rate to systemic adjuvant therapy: results with regard to poor survival in young Chinese breast cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Factors affecting estrogen receptor status in a multiracial Asian country: an analysis of 3557 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Molecular subtype approximated by quantitative estrogen receptor, progesterone receptor and Her2 can predict the prognosis of breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

The prevalence and assessment of ErbB2-positive breast cancer in Asia: a literature survey

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

BRCA1 and BRCA2 mutations in women from Shanghai China

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Breast cancer in China: demand for genetic counseling and genetic testing

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Guideline implementation for breast healthcare in low- and middle-income countries: treatment resource allocation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Development and trends of surgical modalities for breast cancer in China: a review of 16-year data

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

IAEA's role in the global management of cancer-focus on upgrading radiotherapy services

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Patterns of axillary surgical care for breast cancer in the era of sentinel lymph node biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Sentinel node biopsy and quality of life measures in a Chinese population

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Trends in breast cancer treatment in Korea and impact of compliance with consensus recommendations on survival

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

An increased utilisation rate and better compliance to guidelines for primary radiotherapy for breast cancer from 1997 till 2008: a population-based study in the Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Breast cancer in Brazil: present status and future goals

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Epidemiologic study of radiotherapy use in China in patients with breast cancer between 1999 and 2008.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Palliative medicine: barriers and developments in mainland China.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Perceptions of a life review programme among Chinese patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Palliative care education in China: insight into one medical university.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Phase II study of an outpatient palliative care intervention in patients with metastatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Structured pluralism: towards an innovative model for health system reform in Latin America

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Utilization of and Attitudes towards Traditional Chinese Medicine Therapies in a Chinese Cancer Hospital: A Survey of Patients and Physicians

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Establishing an evidence-base for breast cancer control in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Scientific publications from mainland China, Taiwan, and Hong Kong in integrative and complementary medicine journals: a ten-year literature survey.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

HER2 testing in breast cancer: an overview of current techniques and recent developments

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Breast-cancer early detection in low-income and middle-income countries: do what you can versus one size fits all.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

Early results of China's historic health reforms: the view from minister Chen Zhu. Interview by Tsung-Mei Cheng

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2813%2970567-9

7 January 2021

10.1016/S1470-2045(13)70567-9

Identifiers

DOI

1 reference

31 August 2017

1 reference